Publications by authors named "Harm-Henning Lindhof"

Background: Infections of the urogenital tract are recognized as potential contributors to male subfertility or infertility. Ureaplasma parvum is frequently detected in semen samples, yet its specific impact on semen quality and the potential benefit of antibiotic treatment remain uncertain.

Results: In a retrospective cohort of 3,464 semen samples collected for fertility evaluation, Ureaplasma parvum was identified in 12.

View Article and Find Full Text PDF

Background: Melanoma is the main cause of skin cancer-related death. Treatment with immune checkpoint inhibitors (CPI) has improved the prognosis in recent years. However, subtypes of melanoma differ in their response.

View Article and Find Full Text PDF

Positron emission tomography (PET)/computed tomography (CT) imaging is an established tool in diagnosing and staging for various malignancies, however, during immune checkpoint inhibitor (ICI) therapy not only inflammatory changes may mimic disease progression, but also secondary malignancies should be considered in the setting of unusual clinical and radiographic findings. Here, we present the case of a 64-year-old man with a lymphogenic metastatic malignant melanoma treated with ipilimumab/nivolumab, in whom PET/CT indicated tumor progression of an intra-abdominal mass. Biopsy revealed an unusual reactive T-cell expansion without clonal expansion, pathologically consistent with ICI-induced immune response.

View Article and Find Full Text PDF
Article Synopsis
  • - Immune checkpoint inhibitors (ICIs) are important in cancer treatment but can cause immune-related adverse events (irAEs), with musculoskeletal issues being less common but impactful.
  • - The mechanisms of these musculoskeletal irAEs are not well understood, and there are no clear treatment guidelines beyond using glucocorticosteroids.
  • - In the case of a 72-year-old patient with severe ICI-induced polyarthritis unresponsive to glucocorticosteroids, treatment with the IL-17A/F/AF-inhibitor bimekizumab resulted in complete clinical and sonographic recovery.
View Article and Find Full Text PDF